Skip to main content

Trends in Securities Class Actions Involving Life Sciences Companies

Bret Leone-Quick discusses the trends that have emerged with respect to the types of claims being asserted in securities class actions against life sciences companies.

Subscribe To Viewpoints

Author

Breton Leone-Quick is an attorney who advises Mintz clients in the financial services industry in litigation matters and regulatory investigations. He leverages his understanding of federal securities laws and Delaware corporate laws to navigate complex crises and disputes.